Pharma & Biotech
The defence firm highlighted more weakness in its civil aviation business due to the COVID-19 pandemic,...
Remote Monitored Systems sees big opportunity with P2F acquisition
ANGLE’s Parsortix liquid biopsy proving to be more than just a cancer detection device
discoverIE resumes dividends after strong pandemic run
Only registered members can use this feature.
© Proactive Investors 2021.
Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority. Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.